Association of CYP2C19 Loss-of-Function Alleles with Major Adverse Cardiovascular Events of Clopidogrel in Stable Coronary Artery Disease Patients Undergoing Percutaneous Coronary Intervention: Meta-analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association of CYP2C19 Loss-of-Function Alleles with Major Adverse Cardiovascular Events of Clopidogrel in Stable Coronary Artery Disease Patients Undergoing Percutaneous Coronary Intervention: Meta-analysis
Authors
Keywords
-
Journal
CARDIOVASCULAR DRUGS AND THERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-01
DOI
10.1007/s10557-021-07142-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Very short vs. long dual antiplatelet therapy after second generation drug-eluting stents in 35 785 patients undergoing percutaneous coronary interventions: a meta-analysis of randomized controlled trials
- (2020) Stefano Benenati et al. European Heart Journal-Cardiovascular Pharmacotherapy
- Efficacy and safety of short-term 1–3 months versus standard 12 months dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized clinical trials
- (2020) Wen-Jiao Zhang et al. PLATELETS
- Risk of major adverse cardiovascular events of CYP2C19 loss-of-function genotype guided prasugrel/ticagrelor vs clopidogrel therapy for acute coronary syndrome patients undergoing percutaneous coronary intervention: a meta-analysis
- (2020) Mohitosh Biswas et al. PLATELETS
- Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials
- (2019) Raffaele Piccolo et al. LANCET
- CYP2C19 genotype and adverse cardiovascular outcomes after stent implantation in clopidogrel-treated Asian populations: A systematic review and meta-analysis
- (2017) Ziwei Xi et al. PLATELETS
- Patients with both CYP2C19 loss-of-function allele and peripheral endothelial dysfunction are significantly correlated with adverse cardiovascular events following coronary stent implantation
- (2016) Noriaki Tabata et al. Journal of Cardiology
- Clinical Value of CYP2C19 Genetic Testing for Guiding the Antiplatelet Therapy in a Chinese Population
- (2016) De-Liang Shen et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Relationship between clopidogrel-related polymorphisms and variable platelet reactivity at 1 year: A cohort study from Han Chinese
- (2016) Xuebo Liu et al. Journal of Research in Medical Sciences
- Efficacy and safety of P2Y12 inhibitors according to diabetes, age, gender, body mass index and body weight: Systematic review and meta-analyses of randomized clinical trials
- (2015) Francesco Zaccardi et al. ATHEROSCLEROSIS
- Comparison of the effect of CYP2C19 polymorphism on clinical outcome between acute coronary syndrome and stable angina
- (2015) Yuichiro Arima et al. Journal of Cardiology
- CYP2C19 polymorphism and clinical outcomes among patients of different races treated with clopidogrel: A systematic review and meta-analysis
- (2015) Xuan Niu et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- CYP2C19 Genotype Has a Greater Effect on Adverse Cardiovascular Outcomes Following Percutaneous Coronary Intervention and in Asian Populations Treated With Clopidogrel: A Meta-Analysis
- (2014) M. J. Sorich et al. Circulation-Cardiovascular Genetics
- Cytochrome CYP2C19 polymorphism and risk of adverse clinical events in clopidogrel-treated patients: A meta-analysis based on 23,035 subjects
- (2013) Liu Mao et al. Archives of Cardiovascular Diseases
- The CYP2C19 genotype does not impact the long-term prognosis of patients with coronary artery disease
- (2013) Yong Peng et al. ATHEROSCLEROSIS
- CYP2C19 Poor Metabolizer Is Associated With Clinical Outcome of Clopidogrel Therapy in Acute Myocardial Infarction But Not Stable Angina
- (2013) Ho-Sook Kim et al. Circulation-Cardiovascular Genetics
- The impact of CYP2C19 genotype on cardiovascular events and platelet reactivity in patients with coronary artery disease receiving clopidogrel
- (2013) Dimitris Tousoulis et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Routine Assessment of On-Clopidogrel Platelet Reactivity and Gene Polymorphisms in Predicting Clinical Outcome Following Drug-Eluting Stent Implantation in Patients With Stable Coronary Artery Disease
- (2013) Chiara Viviani Anselmi et al. JACC-Cardiovascular Interventions
- Relationship between Cytochrome P450 2C19*2 Polymorphism and Stent Thrombosis following Percutaneous Coronary Intervention in Chinese Patients Receiving Clopidogrel
- (2013) Y Luo et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms (CYP2C19, ABCB1, PON1), Noncompliance, Diet, Smoking, Co-Medications (Including Proton Pump Inhibitors), and Pre-Existent Variability in Platelet Function
- (2013) Andrew L. Frelinger et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Influence of Smoking Status on the Pharmacokinetics and Pharmacodynamics of Clopidogrel and Prasugrel
- (2013) Paul A. Gurbel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Relationship ofCYP2C19*2andCYP2C19*3Gene Polymorphism with Clopidogrel Response Variability and Recurrent Cardiovascular Events in Chinese Patients Undergoing Percutaneous Coronary Intervention
- (2013) Yamin Liu et al. PHARMACOLOGY
- CYP2C19 Phenotype, Stent Thrombosis, Myocardial Infarction, and Mortality in Patients with Coronary Stent Placement in a Chinese Population
- (2013) Xiang Xie et al. PLoS One
- Effect of smoking on comparative efficacy of antiplatelet agents: systematic review, meta-analysis, and indirect comparison
- (2013) Joshua J Gagne et al. BMJ-British Medical Journal
- Meta-Analysis of Cytochrome P450 2C19 Polymorphism and Risk of Adverse Clinical Outcomes Among Coronary Artery Disease Patients of Different Ethnic Groups Treated With Clopidogrel
- (2012) Jae-Sik Jang et al. AMERICAN JOURNAL OF CARDIOLOGY
- Influence of CYP2C19 loss-of-function variants on the antiplatelet effects and cardiovascular events in clopidogrel-treated Chinese patients undergoing percutaneous coronary intervention
- (2012) Jian-Jun Zou et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The influence of CYP2C19*2 and *17 on on-treatment platelet reactivity and bleeding events in patients undergoing elective coronary stenting
- (2012) Ankie M. Harmsze et al. Pharmacogenetics and Genomics
- Standardized Bleeding Definitions for Cardiovascular Clinical Trials
- (2011) Roxana Mehran et al. CIRCULATION
- Meta-analyses of the association between cytochrome CYP2C19 loss- and gain-of-function polymorphisms and cardiovascular outcomes in patients with coronary artery disease treated with clopidogrel
- (2011) Michel Zabalza et al. HEART
- Prospective Evaluation of On-Clopidogrel Platelet Reactivity Over Time in Patients Treated With Percutaneous Coronary Intervention
- (2011) Gianluca Campo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Impact of genetic variants on post-clopidogrel platelet reactivity in patients after elective percutaneous coronary intervention
- (2011) Orsolya Rideg et al. PHARMACOGENOMICS
- Impact of CYP2C19 polymorphism on residual platelet reactivity in patients with coronary heart disease during antiplatelet therapy
- (2010) Koichiro Yamamoto et al. Journal of Cardiology
- Cytochrome P450 2C19 polymorphism is associated with poor clinical outcomes in coronary artery disease patients treated with clopidogrel
- (2010) Bo Jin et al. MOLECULAR BIOLOGY REPORTS
- 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update)
- (2009) Frederick G. Kushner et al. CIRCULATION
- Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention
- (2009) D. Sibbing et al. EUROPEAN HEART JOURNAL
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
- (2009) Alessandro Liberati et al. PLOS MEDICINE
- Cytochrome P450 2C19 681G>A Polymorphism and High On-Clopidogrel Platelet Reactivity Associated With Adverse 1-Year Clinical Outcome of Elective Percutaneous Coronary Intervention With Drug-Eluting or Bare-Metal Stents
- (2008) Dietmar Trenk et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now